459 related articles for article (PubMed ID: 16821273)
1. Enzyme elevation in patients with juvenile dermatomyositis and steroid myopathy.
Naim MY; Reed AM
J Rheumatol; 2006 Jul; 33(7):1392-4. PubMed ID: 16821273
[TBL] [Abstract][Full Text] [Related]
2. Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores.
McCann LJ; Garay SM; Ryan MM; Harris R; Riley P; Pilkington CA
Rheumatology (Oxford); 2007 Aug; 46(8):1363-6. PubMed ID: 17569746
[TBL] [Abstract][Full Text] [Related]
3. Myopathy induced by antimalarial agents: the relevance of screening muscle enzyme levels.
Kalajian AH; Callen JP
Arch Dermatol; 2009 May; 145(5):597-600. PubMed ID: 19451512
[No Abstract] [Full Text] [Related]
4. [Juvenile dermatomyositis].
Martini A; Ravelli A; Aramini L; Ramenghi B
Pediatr Med Chir; 1990; 12(6):587-91. PubMed ID: 2093879
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis.
Maillard SM; Jones R; Owens C; Pilkington C; Woo P; Wedderburn LR; Murray KJ
Rheumatology (Oxford); 2004 May; 43(5):603-8. PubMed ID: 14983103
[TBL] [Abstract][Full Text] [Related]
6. Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM).
Abdul-Aziz R; Yu CY; Adler B; Bout-Tabaku S; Lintner KE; Moore-Clingenpeel M; Spencer CH
Pediatr Rheumatol Online J; 2017 Apr; 15(1):25. PubMed ID: 28403889
[TBL] [Abstract][Full Text] [Related]
7. [Intravenous cyclophosphamide pulse therapy for refractory juvenile dermatomyositis].
Nakashima S; Mori M; Miyamae T; Ito S; Ibe M; Aihara Y; Yokota S
Ryumachi; 2002 Dec; 42(6):895-902. PubMed ID: 12632609
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic inflammatory myopathies in childhood: a brief review of 27 cases.
Lorenzoni PJ; Scola RH; Kay CS; Prevedello PG; Espíndola G; Werneck LC
Pediatr Neurol; 2011 Jul; 45(1):17-22. PubMed ID: 21723454
[TBL] [Abstract][Full Text] [Related]
9. [Signs of steroid myopathy in a group of patients with asthma undergoing continuous steroid therapy].
Bilińska-Kucharska M; Suchnicka R; Małopelszy J; Martynów R; Zarzycki A
Pol Tyg Lek; 1989 Jul; 44(27):632-4. PubMed ID: 2637433
[TBL] [Abstract][Full Text] [Related]
10. Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children.
Pachman LM; Hayford JR; Chung A; Daugherty CA; Pallansch MA; Fink CW; Gewanter HL; Jerath R; Lang BA; Sinacore J; Szer IS; Dyer AR; Hochberg MC
J Rheumatol; 1998 Jun; 25(6):1198-204. PubMed ID: 9632086
[TBL] [Abstract][Full Text] [Related]
11. Clinical spectrum of inflammatory myositis in South India--a ten year study.
Porkodi R; Shanmuganandan K; Parthiban M; Madhavan R; Rajendran P
J Assoc Physicians India; 2002 Oct; 50():1255-8. PubMed ID: 12568209
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use.
Santiago RA; Silva CA; Caparbo VF; Sallum AM; Pereira RM
Scand J Rheumatol; 2008; 37(1):40-7. PubMed ID: 18189194
[TBL] [Abstract][Full Text] [Related]
13. Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy.
Bronner IM; Hoogendijk JE; Wintzen AR; van der Meulen MF; Linssen WH; Wokke JH; de Visser M
J Neurol; 2003 Apr; 250(4):480-5. PubMed ID: 12700915
[TBL] [Abstract][Full Text] [Related]
14. Duration of illness is an important variable for untreated children with juvenile dermatomyositis.
Pachman LM; Abbott K; Sinacore JM; Amoruso L; Dyer A; Lipton R; Ilowite N; Hom C; Cawkwell G; White A; Rivas-Chacon R; Kimura Y; Ray L; Ramsey-Goldman R
J Pediatr; 2006 Feb; 148(2):247-53. PubMed ID: 16492437
[TBL] [Abstract][Full Text] [Related]
15. The arthritis of inflammatory childhood myositis syndromes.
Tse S; Lubelsky S; Gordon M; Al Mayouf SM; Babyn PS; Laxer RM; Silverman ED; Schneider R; Feldman BM
J Rheumatol; 2001 Jan; 28(1):192-7. PubMed ID: 11196524
[TBL] [Abstract][Full Text] [Related]
16. Quantitative muscle testing in childhood dermatomyositis.
Miller LC; Michael AF; Baxter TL; Kim Y
Arch Phys Med Rehabil; 1988 Aug; 69(8):610-3. PubMed ID: 3408331
[TBL] [Abstract][Full Text] [Related]
17. A rare complication of generalized edema in juvenile dermatomyositis: a report of one case.
Karabiber H; Aslan M; Alkan A; Yakinci C
Brain Dev; 2004 Jun; 26(4):269-72. PubMed ID: 15130694
[TBL] [Abstract][Full Text] [Related]
18. Elevation of creatine kinase from skeletal muscle associated with inhaled albuterol.
Craig TJ; Smits W; Soontornniyomkiu V
Ann Allergy Asthma Immunol; 1996 Dec; 77(6):488-90. PubMed ID: 8970440
[TBL] [Abstract][Full Text] [Related]
19. Association among somatic HPRT mutant frequency, peripheral blood T-lymphocyte clonality, and serologic parameters of disease activity in children with juvenile onset dermatomyositis.
Abramson LS; Albertini RJ; Pachman LM; Finette BA
Clin Immunol; 1999 Apr; 91(1):61-7. PubMed ID: 10219255
[TBL] [Abstract][Full Text] [Related]
20. Statin-associated myopathy with normal creatine kinase levels. Case report from a Norwegian family.
Trøseid M; Henriksen OA; Lindal S
APMIS; 2005 Sep; 113(9):635-7. PubMed ID: 16218940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
